IBM INVESTIGATION: IBM Securities Fraud Investigation into IBM Z Product Slowdown is Ongoing – Contact BFA Law if You Lost Money

BFA Law is investigating whether IBM committed securities fraud relating to misrepresentations about the pace of securing new business deals and the strength of its IBM Z product outlook.

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into International Business Machines Corporation (NYSE:IBM) for potential securities fraud after its significant stock drop.

If you invested in IBM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ibm-class-action-lawsuit .

Investigation Overview: Securities fraud relating to IBM’s misrepresentations about the pace of securing new business deals and the strength of its IBM Z product outlook

Stock Decline: July 14, 2026 – 25% Stock Drop

Action: Contact BFA Law to discuss your rights

IBM is being investigated for securities fraud following a significant stock drop. The decline in IBM’s stock price caused significant losses to investors.

IBM is a global technology and consulting company that focuses on hybrid cloud and artificial intelligence. IBM uses IBM Z to deliver enhanced AI acceleration through multi-model AI capabilities, low unit cost architecture at scale for workloads that require end-to-end encryption, continued availability, and ultra-high throughput.

BFA is investigating whether IBM misled investors about its pace securing new business deals and the strength of its IBM Z outlook.

On July 14, 2026, IBM released its 2026 Q2 financial results. IBM announced a disappointing quarter that it attributed to “a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing.” IBM also revealed that it had “faltered,” and “did not adapt and move quickly enough” so that “numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall.”

This news caused the price of IBM stock to decline over $75 in intraday trading on July 14, 2026, or over 25%.

If you invested in IBM, you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting: https://www.bfalaw.com/cases/ibm-class-action-lawsuit

Or contact: Adam McCall [email protected] 212.789.3619